GINI, Beatrice
GINI, Beatrice
DIPARTIMENTO DI SCIENZE NEUROLOGICHE E DEL MOVIMENTO (attivo dal 01/01/2000 al 31/12/2015)
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis.
2011-01-01 Farinazzo, Alessia; Gini, Beatrice; Milli, A.; Ruffini, F.; Marconi, Silvia; Turano, Ermanna; Anghileri, Elena; Barbieri, F.; Cecconi, Daniela; Furlan, R.; Bonetti, Bruno
A proteomic approach to identify autoantigens in Hashimoto's encephalopathy [Un approccio proteomico per l'identificazione di autoantigeni nell'encefalopatia di Hashimoto]
2014-01-01 Farinazzo, Alessia; Gini, Beatrice; Moretto, Giuseppe; Bonetti, Bruno
A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments.
2013-01-01 Masui, K.; Gini, Beatrice; Wykosky, J.; Zanca, C.; Mischel, P. S.; Furnari, F. B.; Cavenee, W. K.
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
2009-01-01 Constantin, Gabriela; Marconi, Silvia; Rossi, Barbara; Angiari, Stefano; Calderan, Laura; Anghileri, Elena; Gini, Beatrice; Bach, Simone Dorothea; Martinello, M.; Bifari, F.; Galie', Mirco; Turano, Ermanna; Budui, Simona Luciana; Sbarbati, Andrea; Krampera, Mauro; Bonetti, Bruno
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
2011-01-01 Guo, D; Reinitz, F; Youssef, M; Hong, C; Nathanson, D; Akhavan, D; Kuga, D; Amzajerdi, An; Soto, H; Zhu, S; Babic, I; Tanaka, K; Dang, J; Iwanami, A; Gini, Beatrice; Dejesus, J; Lisiero, Dd; Huang, Tt; Prins, Rm; Wen, Py; Robins, Hi; Prados, Md; Deangelis, Lm; Mellinghoff, Ik; Mehta, Mp; James, Cd; Chakravarti, A; Cloughesy, Tf; Tontonoz, P; Mischel, Ps
BIOMOLECULAR TECHNOLOGIES IN THE STUDY OF CENTRAL NERVOUS SYSTEM DISEASES
2011-01-01 Gini, Beatrice
Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains
2008-01-01 Sotgiu, S.; Musumeci, S.; Marconi, Silvia; Gini, Beatrice; Bonetti, Bruno
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.
2013-01-01 Babic, I.; Anderson, E. S.; Tanaka, K.; Guo, D.; Masui, K.; Li, B.; Zhu, S.; Gu, Y.; Villa, G. R.; Akhavan, D.; Nathanson, D.; Gini, Beatrice; Mareninov, S.; Li, R.; Camacho, C. E.; Kurdistani, S. K.; Eskin, A.; Nelson, S. F.; Yong, W. H.; Cavenee, W. K.; Cloughesy, T. F.; Christofk, H. R.; Black, D. L.; Mischel, P. S.
Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM.
2014-01-01 Gini, Beatrice; Mischel, P. S.
Hashimoto encephalopathy and antibodies against dimethylargininase-1: a rare cause of cognitive decline in a pediatric Down's syndrome patient.
2011-01-01 Verhelst, H.; Verloo, P.; De Paepe, B.; Gini, Beatrice; Bonetti, Bruno; Van Coster, R.
Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla.
2012-01-01 Chaumeil, M. M.; Gini, Beatrice; Yang, H.; Iwanami, A.; Sukumar, S.; Ozawa, T.; Pieper, R. O.; Mischel, P. S.; James, C. D.; Berger, M. S.; Ronen, S. M.
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
2013-01-01 Masui, K.; Tanaka, K.; Akhavan, D.; Babic, I.; Gini, Beatrice; Matsutani, T.; Iwanami, A.; Liu, F.; Villa, G. R.; Gu, Y.; Campos, C.; Zhu, S.; Yang, H.; Yong, W. H.; Cloughesy, T. F.; Mellinghoff, I. K.; Cavenee, W. K.; Shaw, R. J.; Mischel, P. S.
Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach
2008-01-01 Gini, Beatrice; Lovato, Laura; Cianti, R.; Cecotti, L.; Marconi, Silvia; Anghileri, Elena; Armini, A.; Moretto, G.; Bini, L.; Ferracci, F.; Bonetti, Bruno
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
2011-01-01 Tanaka, K; Babic, I; Nathanson, D; Akhavan, D; Guo, D; Gini, Beatrice; Dang, J; Zhu, S; Yang, H; De Jesus, J; Amzajerdi, An; Zhang, Y; Dibble, Cc; Dan, H; Rinkenbaugh, A; Yong, Wh; Vinters, Hv; Gera, Jf; Cavenee, Wk; Cloughesy, Tf; Manning, Bd; Baldwin, As; Mischel, Ps
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
2013-01-01 Iwanami, A.; Gini, Beatrice; Zanca, C.; Matsutani, T.; Assuncao, A.; Nael, A.; Dang, J.; Yang, H.; Zhu, S.; Kohyama, J.; Kitabayashi, I.; Cavenee, W. K.; Cloughesy, T. F.; Furnari, F. B.; Nakamura, M.; Toyama, Y.; Okano, H.; Mischel, P. S.
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE
2008-01-01 Marconi, Silvia; Rossi, Barbara; Angiari, Stefano; Gini, Beatrice; Bach Simone, Dorothea; Martinello, Marianna; Sbarbati, Andrea; Krampera, Mauro; Constantin, Gabriela; Bonetti, Bruno
Recombinant inbred systems can advance research in behavioral ecology.
2012-01-01 Gini, Beatrice; Hager, R.
Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma
2016-01-01 Wei, Wei; Shin, Young Shik; Xue, Min; Matsutani, Tomoo; Masui, Kenta; Yang, Huijun; Ikegami, Shiro; Gu, Yuchao; Herrmann, Ken; Johnson, Dazy; Ding, Xiangming; Hwang, Kiwook; Kim, Jungwoo; Zhou, Jian; Su, Yapeng; Li, Xinmin; Bonetti, Bruno; Chopra, Rajesh; James, C. David; Cavenee, Webster K; Cloughesy, Timothy F; Mischel, Paul S; Heath, James R; Gini, Beatrice
Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.
2014-01-01 Nathanson, D. A.; Gini, Beatrice; Mottahedeh, J.; Visnyei, K.; Koga, T.; Gomez, G.; Eskin, A.; Hwang, K.; Wang, J.; Masui, K.; Paucar, A.; Yang, H.; Ohashi, M.; Zhu, S.; Wykosky, J.; Reed, R.; Nelson, S. F.; Cloughesy, T. F.; James, C. D.; Rao, P. N.; Kornblum, H. I.; Heath, J. R.; Cavenee, W. K.; Furnari, F. B.; Mischel, P. S.
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.
2013-01-01 Gini, Beatrice; Zanca, C.; Guo, D.; Matsutani, T.; Masui, K.; Ikegami, S.; Yang, H.; Nathanson, D.; Villa, G.; Shackelford, D.; Zhu, S.; Tanaka, K.; Babic, I.; Akhavan, D.; Lin, K.; Assuncao, A.; Gu, Y.; Bonetti, Bruno; Mortensen, D. S.; Xu, S.; Raymon, H.; Cavenee, W. K.; Furnari, F. B.; James, C. D.; Kroemer, G.; Heath, J. R.; Hege, K.; Chopra, . R.; Cloughesy, T. F.; Mischel, P. S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis. | 1-gen-2011 | Farinazzo, Alessia; Gini, Beatrice; Milli, A.; Ruffini, F.; Marconi, Silvia; Turano, Ermanna; Anghileri, Elena; Barbieri, F.; Cecconi, Daniela; Furlan, R.; Bonetti, Bruno | |
| A proteomic approach to identify autoantigens in Hashimoto's encephalopathy [Un approccio proteomico per l'identificazione di autoantigeni nell'encefalopatia di Hashimoto] | 1-gen-2014 | Farinazzo, Alessia; Gini, Beatrice; Moretto, Giuseppe; Bonetti, Bruno | |
| A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. | 1-gen-2013 | Masui, K.; Gini, Beatrice; Wykosky, J.; Zanca, C.; Mischel, P. S.; Furnari, F. B.; Cavenee, W. K. | |
| Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. | 1-gen-2009 | Constantin, Gabriela; Marconi, Silvia; Rossi, Barbara; Angiari, Stefano; Calderan, Laura; Anghileri, Elena; Gini, Beatrice; Bach, Simone Dorothea; Martinello, M.; Bifari, F.; Galie', Mirco; Turano, Ermanna; Budui, Simona Luciana; Sbarbati, Andrea; Krampera, Mauro; Bonetti, Bruno | |
| An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. | 1-gen-2011 | Guo, D; Reinitz, F; Youssef, M; Hong, C; Nathanson, D; Akhavan, D; Kuga, D; Amzajerdi, An; Soto, H; Zhu, S; Babic, I; Tanaka, K; Dang, J; Iwanami, A; Gini, Beatrice; Dejesus, J; Lisiero, Dd; Huang, Tt; Prins, Rm; Wen, Py; Robins, Hi; Prados, Md; Deangelis, Lm; Mellinghoff, Ik; Mehta, Mp; James, Cd; Chakravarti, A; Cloughesy, Tf; Tontonoz, P; Mischel, Ps | |
| BIOMOLECULAR TECHNOLOGIES IN THE STUDY OF CENTRAL NERVOUS SYSTEM DISEASES | 1-gen-2011 | Gini, Beatrice | |
| Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains | 1-gen-2008 | Sotgiu, S.; Musumeci, S.; Marconi, Silvia; Gini, Beatrice; Bonetti, Bruno | |
| EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. | 1-gen-2013 | Babic, I.; Anderson, E. S.; Tanaka, K.; Guo, D.; Masui, K.; Li, B.; Zhu, S.; Gu, Y.; Villa, G. R.; Akhavan, D.; Nathanson, D.; Gini, Beatrice; Mareninov, S.; Li, R.; Camacho, C. E.; Kurdistani, S. K.; Eskin, A.; Nelson, S. F.; Yong, W. H.; Cavenee, W. K.; Cloughesy, T. F.; Christofk, H. R.; Black, D. L.; Mischel, P. S. | |
| Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM. | 1-gen-2014 | Gini, Beatrice; Mischel, P. S. | |
| Hashimoto encephalopathy and antibodies against dimethylargininase-1: a rare cause of cognitive decline in a pediatric Down's syndrome patient. | 1-gen-2011 | Verhelst, H.; Verloo, P.; De Paepe, B.; Gini, Beatrice; Bonetti, Bruno; Van Coster, R. | |
| Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. | 1-gen-2012 | Chaumeil, M. M.; Gini, Beatrice; Yang, H.; Iwanami, A.; Sukumar, S.; Ozawa, T.; Pieper, R. O.; Mischel, P. S.; James, C. D.; Berger, M. S.; Ronen, S. M. | |
| mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. | 1-gen-2013 | Masui, K.; Tanaka, K.; Akhavan, D.; Babic, I.; Gini, Beatrice; Matsutani, T.; Iwanami, A.; Liu, F.; Villa, G. R.; Gu, Y.; Campos, C.; Zhu, S.; Yang, H.; Yong, W. H.; Cloughesy, T. F.; Mellinghoff, I. K.; Cavenee, W. K.; Shaw, R. J.; Mischel, P. S. | |
| Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach | 1-gen-2008 | Gini, Beatrice; Lovato, Laura; Cianti, R.; Cecotti, L.; Marconi, Silvia; Anghileri, Elena; Armini, A.; Moretto, G.; Bini, L.; Ferracci, F.; Bonetti, Bruno | |
| Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. | 1-gen-2011 | Tanaka, K; Babic, I; Nathanson, D; Akhavan, D; Guo, D; Gini, Beatrice; Dang, J; Zhu, S; Yang, H; De Jesus, J; Amzajerdi, An; Zhang, Y; Dibble, Cc; Dan, H; Rinkenbaugh, A; Yong, Wh; Vinters, Hv; Gera, Jf; Cavenee, Wk; Cloughesy, Tf; Manning, Bd; Baldwin, As; Mischel, Ps | |
| PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. | 1-gen-2013 | Iwanami, A.; Gini, Beatrice; Zanca, C.; Matsutani, T.; Assuncao, A.; Nael, A.; Dang, J.; Yang, H.; Zhu, S.; Kohyama, J.; Kitabayashi, I.; Cavenee, W. K.; Cloughesy, T. F.; Furnari, F. B.; Nakamura, M.; Toyama, Y.; Okano, H.; Mischel, P. S. | |
| Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE | 1-gen-2008 | Marconi, Silvia; Rossi, Barbara; Angiari, Stefano; Gini, Beatrice; Bach Simone, Dorothea; Martinello, Marianna; Sbarbati, Andrea; Krampera, Mauro; Constantin, Gabriela; Bonetti, Bruno | |
| Recombinant inbred systems can advance research in behavioral ecology. | 1-gen-2012 | Gini, Beatrice; Hager, R. | |
| Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma | 1-gen-2016 | Wei, Wei; Shin, Young Shik; Xue, Min; Matsutani, Tomoo; Masui, Kenta; Yang, Huijun; Ikegami, Shiro; Gu, Yuchao; Herrmann, Ken; Johnson, Dazy; Ding, Xiangming; Hwang, Kiwook; Kim, Jungwoo; Zhou, Jian; Su, Yapeng; Li, Xinmin; Bonetti, Bruno; Chopra, Rajesh; James, C. David; Cavenee, Webster K; Cloughesy, Timothy F; Mischel, Paul S; Heath, James R; Gini, Beatrice | |
| Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. | 1-gen-2014 | Nathanson, D. A.; Gini, Beatrice; Mottahedeh, J.; Visnyei, K.; Koga, T.; Gomez, G.; Eskin, A.; Hwang, K.; Wang, J.; Masui, K.; Paucar, A.; Yang, H.; Ohashi, M.; Zhu, S.; Wykosky, J.; Reed, R.; Nelson, S. F.; Cloughesy, T. F.; James, C. D.; Rao, P. N.; Kornblum, H. I.; Heath, J. R.; Cavenee, W. K.; Furnari, F. B.; Mischel, P. S. | |
| The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. | 1-gen-2013 | Gini, Beatrice; Zanca, C.; Guo, D.; Matsutani, T.; Masui, K.; Ikegami, S.; Yang, H.; Nathanson, D.; Villa, G.; Shackelford, D.; Zhu, S.; Tanaka, K.; Babic, I.; Akhavan, D.; Lin, K.; Assuncao, A.; Gu, Y.; Bonetti, Bruno; Mortensen, D. S.; Xu, S.; Raymon, H.; Cavenee, W. K.; Furnari, F. B.; James, C. D.; Kroemer, G.; Heath, J. R.; Hege, K.; Chopra, . R.; Cloughesy, T. F.; Mischel, P. S. |